
	Chemical structure search How to Search	Import MOLfile format is only available (V3000 format is not available) Exact match Substructure search Superstructure search Substructure or superstructure search Similarity search

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr

J-GLOBAL ID：201801020651336278 Update date: Mar. 19, 2025

Sato Tatsuhiro

サトウタツヒロ | Sato Tatsuhiro

Affiliation and department：
Homepage URL (1)： https://cancer-c.pref.aichi.jp/site/folder5/1513.html

Research field (1)： Cell biology

Research keywords (1)：がん細胞、mTOR、Rheb、NF2、YAP/TAZ、Hippo経路

Papers (32)：

Ken Akao, Tatsuhiro Sato, Emi Mishiro-Sato, Satomi Mukai, Farhana Ishrat Ghani, Lisa Kondo-Ida, Kazuyoshi Imaizumi, Yoshitaka Sekido. TEAD-independent cell growth of Hippo-inactive mesothelioma cells: Unveiling resistance to TEAD inhibitor K-975 through MYC signaling activation. Molecular cancer therapeutics. 2024
Tatsuhiro Sato, Ken Akao, Ayuko Sato, Tohru Tsujimura, Satomi Mukai, Yoshitaka Sekido. Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations. Cancer medicine. 2023. 12. 12. 13586-13598
Yoshitaka Sekido, Tatsuhiro Sato. NF2 alteration in mesothelioma. Frontiers in Toxicology. 2023. 5
Koya Suzuki, Masaki Tange, Ryota Yamagishi, Hiroyuki Hanada, Satomi Mukai, Tatsuhiro Sato, Takeshi Tanaka, Tomohiro Akashi, Kenji Kadomatsu, Tohru Maeda, et al. SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma. Cell Death Discovery. 2022. 8. 1
Tatsuhiro Sato, Hayao Nakanishi, Ken Akao, Maho Okuda, Satomi Mukai, Tohru Kiyono, Yoshitaka Sekido. Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively. Cancer cell international. 2021. 21. 1. 546-546

MISC (8)：

向井智美, 佐藤龍洋, 三城恵美, 青木正博, 藪田紀一, 関戸好孝. Therapeutic potential of nuclear transport inhibition for cancers with increased O-GlcNAcylation. 日本癌学会学術総会抄録集(Web). 2024. 83rd
向井智美, 佐藤龍洋, 亀井保博, 加藤輝, 三城恵美, 三城恵美, 青木正博, 藪田紀一, 廣島健三, 関戸好孝. ヌクレオポリンのO-GlcNAc修飾異常に伴う腫瘍進展機構の解明. 日本分子生物学会年会プログラム・要旨集(Web). 2024. 47th
赤尾謙, 佐藤龍洋, 向井智美, 平野雅規, 関戸好孝. 新規TEAD阻害剤の悪性中皮腫細胞株に対する抗腫瘍効果の検討(Investigation of tumor suppressive effects of novel TEAD inhibitors on malignant mesothelioma cell lines). 日本癌学会総会記事. 2022. 81回. P-2363
小玉勇太, 田中一大, 佐藤龍洋, 堀和美, 玄崇永, 森瀬昌宏, 佐藤光夫, 関戸好孝. 悪性中皮腫におけるオキシトシン受容体(OXTR)を標的とした新規治療法の開発. 肺癌. 2021. 61. 6. 766-766
Sato T, Nakashima A, Tamanoi F. Rheb-mTOR signaling pathway involved in tumor formation. 2010. 55. 1. 11-17

Lectures and oral presentations (5)：

核と細胞質を繋ぐ核膜孔と様々な生命現象ヌクレオポリンの翻訳後修飾異常に着目した、YAP/TAZの活性化を伴うがんに対する新規治療の可能性
(第96回日本生化学会大会 2023)
Rheb-CADシグナル伝達経路によるピリミジンヌクレオチド生合成促進機構
(日本生化学会大会・日本分子生物学会年会合同大会講演要旨集 2015)
Proteomic identification of novel tyrosine-sulfated proteins
(日本プロテオーム学会大会プログラム・抄録集 2015)
in vitroリン酸化法による新規ERK基質候補の同定
(日本生化学会大会・日本分子生物学会年会合同大会講演要旨集 2010)
プロテオミクス技術によるラパマイシン非感受性mTORシグナル伝達系の解析
(日本生化学会大会・日本分子生物学会年会合同大会講演要旨集 2010)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.


	Free word	※Add the following synonyms, you can increase the number of hits.




		～